| Apr 30, 2024 |
May 6, 2024 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
30.0
|
-4,700
|
-6.58%
|
✓
|
$414.6K |
| Mar 15, 2024 |
Mar 19, 2024 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
17.5
|
-22,580
|
-24.01%
|
✗
|
$1.9M |
| Mar 5, 2024 |
Mar 7, 2024 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
35.0
|
-4,000
|
-4.08%
|
✓
|
$348.3K |
| Sep 18, 2023 |
Sep 20, 2023 |
NEKTAR THERAPEUTICS
|
Director |
Sell |
27.5
|
-4,359
|
-11.32%
|
✗
|
$3K |
| Apr 28, 2023 |
Aug 17, 2023 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
30.0
|
-4,682
|
-7.15%
|
✓
|
$450K |
| Mar 15, 2023 |
Mar 17, 2023 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
17.5
|
-14,371
|
-18.00%
|
✗
|
$2.3M |
| Jan 25, 2023 |
Jan 27, 2023 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
3.8
|
-49,000
|
-54.39%
|
✓
|
$5.7M |
| Nov 2, 2022 |
Nov 4, 2022 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
30.0
|
-3,000
|
-6.80%
|
✓
|
$258.4K |
| Sep 23, 2022 |
Sep 26, 2022 |
NEKTAR THERAPEUTICS
|
Director |
Sell |
26.3
|
-4,198
|
-9.83%
|
✗
|
$13.3K |
| Aug 11, 2022 |
Aug 12, 2022 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
30.0
|
-3,000
|
-6.37%
|
✓
|
$286.9K |
| Jun 3, 2022 |
Jun 7, 2022 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
20.0
|
-7,021
|
-12.98%
|
✗
|
$544.1K |
| Apr 29, 2022 |
May 31, 2022 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
45.0
|
-968
|
-1.76%
|
✓
|
$103.3K |
| Apr 13, 2022 |
Apr 14, 2022 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
41.3
|
-1,180
|
-2.10%
|
✓
|
$97.3K |
| Mar 29, 2022 |
Mar 31, 2022 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
32.5
|
-2,999
|
-5.06%
|
✓
|
$238.4K |
| Mar 22, 2022 |
Mar 24, 2022 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
22.5
|
-8,202
|
-12.16%
|
✓
|
$669.1K |
| Mar 15, 2022 |
Mar 17, 2022 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
90.0
|
+2,235
|
3.43%
|
✗
|
$762.8K |
| Apr 30, 2021 |
Oct 28, 2021 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
37.5
|
-2,397
|
-4.12%
|
✓
|
$201.6K |
| Sep 22, 2021 |
Sep 24, 2021 |
NEKTAR THERAPEUTICS
|
Director |
Sell |
95.0
|
+6,535
|
25.16%
|
✗
|
$65.2K |
| Apr 8, 2021 |
Apr 9, 2021 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
41.3
|
-1,537
|
-2.57%
|
✓
|
$121.1K |
| Mar 30, 2021 |
Apr 1, 2021 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
41.3
|
-1,652
|
-2.69%
|
✓
|
$123.6K |
| Mar 24, 2021 |
Mar 26, 2021 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
45.0
|
-1,181
|
-1.89%
|
✓
|
$90.1K |
| Mar 22, 2021 |
Mar 23, 2021 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
22.5
|
-1,513
|
-2.36%
|
✗
|
$118.8K |
| Mar 18, 2021 |
Mar 19, 2021 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
45.0
|
-1,308
|
-2.00%
|
✓
|
$102K |
| Mar 15, 2021 |
Mar 17, 2021 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
92.5
|
+4,160
|
6.79%
|
✗
|
$512.7K |
| Oct 14, 2020 |
Oct 15, 2020 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
37.5
|
-2,121
|
-3.35%
|
✓
|
$169.5K |
| Sep 28, 2020 |
Sep 30, 2020 |
NEKTAR THERAPEUTICS
|
Director |
Sell |
25.0
|
-3,250
|
-11.12%
|
✓
|
$56.1K |
| Sep 21, 2020 |
Sep 21, 2020 |
NEKTAR THERAPEUTICS
|
Director |
Sell |
28.8
|
-2,250
|
-10.06%
|
✓
|
$44.4K |
| Apr 30, 2020 |
Jun 23, 2020 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
20.0
|
-14,662
|
-10.36%
|
✓
|
$1.9M |
| Apr 8, 2020 |
Apr 9, 2020 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
37.5
|
-2,407
|
-3.68%
|
✓
|
$192.5K |
| Apr 1, 2020 |
Apr 2, 2020 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
41.3
|
-1,537
|
-2.29%
|
✓
|
$126K |
| Mar 24, 2020 |
Mar 26, 2020 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
30.0
|
-3,659
|
-5.18%
|
✓
|
$278.7K |
| Mar 20, 2020 |
Mar 24, 2020 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
20.0
|
-3,599
|
-4.85%
|
✗
|
$262.9K |
| Mar 13, 2020 |
Mar 17, 2020 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
90.0
|
+2,736
|
3.82%
|
✗
|
$645.9K |
| Sep 30, 2019 |
Oct 1, 2019 |
NEKTAR THERAPEUTICS
|
Director |
Sell |
32.5
|
-2,375
|
-9.60%
|
✓
|
$42.9K |
| Sep 20, 2019 |
Sep 24, 2019 |
NEKTAR THERAPEUTICS
|
Director |
Sell |
28.8
|
-2,250
|
-10.98%
|
✓
|
$45.5K |
| Mar 26, 2019 |
Mar 27, 2019 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
30.0
|
-3,656
|
-7.15%
|
✓
|
$326K |
| Mar 22, 2019 |
Mar 26, 2019 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
20.0
|
-3,598
|
-6.57%
|
✗
|
$316.8K |
| Mar 21, 2019 |
Mar 25, 2019 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
26.3
|
-4,519
|
-7.63%
|
✓
|
$406.6K |
| Mar 19, 2019 |
Mar 21, 2019 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
30.0
|
-3,728
|
-5.92%
|
✓
|
$347K |
| Mar 15, 2019 |
Mar 19, 2019 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
90.0
|
+2,201
|
3.62%
|
✗
|
$677.7K |
| Mar 1, 2019 |
Mar 5, 2019 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
95.0
|
+11,640
|
23.69%
|
✗
|
$86.9K |
| Nov 14, 2018 |
Nov 16, 2018 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
17.5
|
-9,000
|
-15.48%
|
✓
|
$829.4K |
| Oct 3, 2018 |
Oct 5, 2018 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
45.0
|
-1,000
|
-1.99%
|
✓
|
$99K |
| Sep 20, 2018 |
Sep 21, 2018 |
NEKTAR THERAPEUTICS
|
Director |
Sell |
7.5
|
-6,750
|
-30.00%
|
✓
|
$383.1K |
| Jun 11, 2018 |
Jun 13, 2018 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
41.3
|
-1,436
|
-2.78%
|
✓
|
$129.7K |
| Jun 4, 2018 |
Jun 6, 2018 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
22.5
|
-1,414
|
-2.67%
|
✗
|
$130.2K |
| Apr 30, 2018 |
May 9, 2018 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
57.5
|
-
|
0.00%
|
✓
|
$26.6K |
| Mar 22, 2018 |
Apr 27, 2018 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
20.0
|
-3,598
|
-5.98%
|
✗
|
$292.7K |
| Apr 2, 2018 |
Apr 3, 2018 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
37.5
|
-2,119
|
-3.85%
|
✓
|
$169.8K |
| Mar 29, 2018 |
Mar 30, 2018 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
41.3
|
-1,537
|
-2.72%
|
✓
|
$122.5K |
| Mar 22, 2018 |
Mar 26, 2018 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
20.0
|
-3,583
|
-5.96%
|
✗
|
$291.5K |
| Mar 21, 2018 |
Mar 23, 2018 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
30.0
|
-4,368
|
-6.77%
|
✓
|
$366.5K |
| Mar 15, 2018 |
Mar 19, 2018 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
97.5
|
+9,189
|
16.61%
|
✗
|
$305.1K |
| Mar 9, 2018 |
Mar 13, 2018 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
32.5
|
-2,972
|
-5.10%
|
✓
|
$244.9K |
| Mar 2, 2018 |
Mar 6, 2018 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
22.5
|
-1,614
|
-2.69%
|
✗
|
$128.9K |
| Sep 22, 2017 |
Sep 26, 2017 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
35.0
|
-3,521
|
-3.54%
|
✓
|
$334.5K |
| Jun 7, 2017 |
Jun 9, 2017 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
41.3
|
-1,004
|
-2.05%
|
✓
|
$90K |
| Jun 2, 2017 |
Jun 6, 2017 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
22.5
|
-1,488
|
-2.95%
|
✗
|
$135K |
| May 15, 2017 |
May 17, 2017 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
22.5
|
-1,096
|
-2.13%
|
✗
|
$100.3K |
| May 5, 2017 |
May 9, 2017 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
35.0
|
-4,486
|
-4.17%
|
✓
|
$444.1K |
| Apr 28, 2017 |
May 4, 2017 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
57.5
|
-
|
0.00%
|
✓
|
$29.2K |
| Mar 29, 2017 |
Mar 31, 2017 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
30.0
|
-3,890
|
-7.02%
|
✓
|
$346.8K |
| Mar 15, 2017 |
Mar 17, 2017 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
20.0
|
-3,288
|
-7.07%
|
✗
|
$304.1K |
| Mar 7, 2017 |
Mar 8, 2017 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
26.3
|
-5,000
|
-9.71%
|
✓
|
$452.8K |
| Mar 3, 2017 |
Mar 7, 2017 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
22.5
|
-1,749
|
-3.28%
|
✗
|
$164.3K |
| Sep 27, 2016 |
Sep 29, 2016 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
5.0
|
-18,467
|
-30.88%
|
✓
|
$1.8M |
| Jun 3, 2016 |
Jun 7, 2016 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
22.5
|
-1,488
|
-2.43%
|
✗
|
$133.9K |
| May 13, 2016 |
May 17, 2016 |
BIOMARIN PHARMACEUTICAL INC
|
EVP, Chief Commercial Officer |
Sell |
22.5
|
-1,096
|
-1.76%
|
✗
|
$90.7K |